EU seals second COVID-19 vaccine deal
BRUSSELS : The European Union has agreed to buy a potential COVID-19 vaccine from Sanofi and GSK in its second such deal to secure supplies, as a deadline for signing up to the World Health Organization’s vaccine purchase programme looms.
The deal will see the French and British drugmakers, which have teamed up to manufacture a recombinant protein-based vaccine they hope to get approved next year, provide the EU with up to 300 million doses, according to a tweet from European Health Commissioner Stella Kyriakides.
Friday’s agreement confirms an announcement made on July 31 by the two companies and follows an earlier deal between the EU and AstraZeneca for up to 400 million shots.
In return for the right to the doses, the European Commission will finance part of the upfront costs faced by vaccine producers. The vaccine doses themselves will be bought by EU countries.
Related News
Blinken back in China seeking pressure but also stability
SHANGHAI, APR 24 (AFP/APP/DNA): US Secretary of State Antony Blinken returned Wednesday to China onRead More
US cautions against ‘potential threat of sanctions’ over Pakistan-Iran agreements
WASHINGTON, APR 23: The Spokesperson of the US Department of State recently addressed concerns regardingRead More
Comments are Closed